Summary
McKesson Corporation's 10-Q filing for the quarter ended June 30, 2004, reveals a company in solid financial standing, demonstrating continued operational strength. The report focuses on the condensed financial statements, management's discussion and analysis, and market risk disclosures, providing investors with key insights into the company's performance and financial health during the period. Investors should pay close attention to the company's revenue growth, profitability trends, and cash flow generation as indicators of its ongoing operational success and ability to manage its business effectively. The filing indicates McKesson's commitment to transparency and provides a detailed look at its financial condition. The Management's Discussion and Analysis section is particularly important for understanding the factors driving the company's results, including any significant operational changes, strategic initiatives, or challenges faced. This period's report sets the stage for understanding McKesson's trajectory in the evolving healthcare distribution landscape.
Key Highlights
- 1The report contains condensed financial statements, including Consolidated Balance Sheets as of June 30, 2004, and March 31, 2004.
- 2Consolidated Statements of Operations for the quarters ended June 30, 2004, and 2003 are presented, offering a year-over-year comparison of performance.
- 3Consolidated Statements of Cash Flows for the quarters ended June 30, 2004, and 2003 are available, detailing cash movements from operating, investing, and financing activities.
- 4The filing includes detailed Financial Notes, providing crucial supplementary information to the condensed financial statements.
- 5Management's Discussion and Analysis of Results of Operations and Financial Condition (Financial Review) offers insights into the company's performance drivers and strategic outlook.
- 6Quantitative and Qualitative Disclosures about Market Risk are provided, highlighting how McKesson manages exposure to various market risks.
- 7Information on Legal Proceedings and Changes in Securities, Use of Proceeds, and Issuer Purchases of Equity Securities are included in Part II, which may be relevant for understanding potential liabilities or shareholder-impacting events.